1700008K24Rik Inhibitors
Chemical inhibitors of 1700008K24Rik can act through various mechanisms to inhibit its function by targeting different parts of cellular signaling pathways. Staurosporine is a broad-spectrum protein kinase inhibitor that can prevent the phosphorylation processes vital for the activity of 1700008K24Rik. By inhibiting these kinases, Staurosporine disrupts the activation and subsequent signaling that typically occurs. Similar in their targets but more specific in action are Wortmannin and LY294002, both of which inhibit PI3K. This inhibition can alter 1700008K24Rik's function by modifying the phosphorylation status of the protein or its substrates, thereby preventing proper signaling and activity.
Further down the signaling cascade, PD98059 and U0126 inhibit MEK, another kinase that acts upstream of proteins like 1700008K24Rik. By blocking MEK, these inhibitors prevent the activation of downstream targets that might be essential for 1700008K24Rik's role in the cell. SB203580 and SP600125 specifically inhibit p38 MAP kinase and JNK, respectively, potentially leading to the functional inhibition of 1700008K24Rik by disrupting signaling pathways involved in the stress response of the cell. Erlotinib, Gefitinib, and Lapatinib target the EGFR family of tyrosine kinases, which can interrupt the signaling networks involving 1700008K24Rik. Finally, multi-target inhibitors like Sorafenib and Sunitinib inhibit several receptor tyrosine kinases, therefore blocking multiple pathways that could regulate the activity of 1700008K24Rik, leading to a broad inhibition of its function by limiting phosphorylation-dependent signaling events.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine can inhibit various protein kinases, which could lead to the functional inhibition of 1700008K24Rik by preventing phosphorylation processes that are essential for its activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of PI3K, a kinase that may participate in signaling pathways that regulate 1700008K24Rik, leading to functional inhibition by altering phosphorylation status of the protein or related substrates. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, similar to Wortmannin, is a PI3K inhibitor which could disrupt signaling cascades necessary for 1700008K24Rik's function, inhibiting its activity by affecting phosphorylation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, which could lead to the functional inhibition of 1700008K24Rik by blocking the activation of downstream targets within its signaling pathway that may be important for the protein's biological role. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor, which could lead to the functional inhibition of 1700008K24Rik by preventing the MEK-mediated activation of downstream signaling molecules or pathways that are crucial for the protein's activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically inhibits p38 MAP kinase, which could inhibit signaling pathways involving 1700008K24Rik, particularly those related to stress response, thereby functionally inhibiting the protein. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, potentially leading to the functional inhibition of 1700008K24Rik by disrupting the JNK signaling pathway which may regulate the protein's activity, especially in response to cellular stress. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib inhibits EGFR tyrosine kinase, which could disrupt signaling networks that 1700008K24Rik is involved in, leading to functional inhibition by downregulating activity pathways essential for the protein's function. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib, an EGFR inhibitor, could functionally inhibit 1700008K24Rik by blocking the EGFR signaling that may be integral for signaling pathways involving the protein, thus reducing its activity. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Lapatinib inhibits both EGFR and HER2/neu tyrosine kinases, potentially leading to the functional inhibition of 1700008K24Rik by disrupting the complex signaling network which the protein may be part of, affecting its activity. | ||||||